Mark Talamonti to Time Factors
This is a "connection" page, showing publications Mark Talamonti has written about Time Factors.
Connection Strength
0.273
-
Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study. J Eur Acad Dermatol Venereol. 2018 Oct; 32(10):1737-1744.
Score: 0.086
-
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009 Jan; 249(1):63-71.
Score: 0.045
-
National failure to operate on early stage pancreatic cancer. Ann Surg. 2007 Aug; 246(2):173-80.
Score: 0.041
-
Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg. 2002 May; 137(5):564-70; discussion 570-1.
Score: 0.028
-
The extent of vascular resection is associated with perioperative outcome in patients undergoing pancreaticoduodenectomy. HPB (Oxford). 2018 02; 20(2):140-146.
Score: 0.021
-
Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience. Ann Surg Oncol. 2017 Sep; 24(9):2770-2776.
Score: 0.020
-
Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011 Apr; 253(4):779-85.
Score: 0.013
-
Early reexploration for excessive postoperative bleeding lowers wound complication rates in open heart surgery. Am Surg. 1987 Feb; 53(2):102-4.
Score: 0.010
-
LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. Neoplasia. 2005 Apr; 7(4):417-25.
Score: 0.009